Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases

Autoimmunity Reviews

Volumn 1, Issue 1-2, 2002, Pages 67-72

  Wiik, Allan ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

ANCA, anti neutrophil cytoplasmic antibodies; Anti neutrophil cytoplasm antibodies; Anti neutrophil nuclear antibodies; CD, Crohn's disease; Chronic inflammatory bowel disease; CIBD, chronic inflammatory bowel diseases; Neutrophil specific autoantibodies

Indexed keywords

ANTIGEN; AUTOANTIBODY; AUTOANTIGEN; ELASTASE; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B2 PROTEIN; HYDRALAZINE; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROCAINAMIDE; PROPYLTHIOURACIL; TETRACYCLINE DERIVATIVE;

ANTIBODY DETECTION; ANTIBODY SCREENING; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CHRONIC ACTIVE HEPATITIS; CHRONIC DISEASE; CHRONIC INFLAMMATION; CROHN DISEASE; CYTOPLASM; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; ENTERITIS; ENZYME IMMUNOASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; LABORATORY TEST; LUPUS VULGARIS; MOLECULAR RECOGNITION; NEUTROPHIL; NOMENCLATURE; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; RHEUMATOID ARTHRITIS; SMALL VESSEL VASCULITIS; STAINING; TARGET CELL; TECHNIQUE; ULCERATIVE COLITIS; VASCULITIS; ANIMAL; ANTIBODY SPECIFICITY; IMMUNOLOGY;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODY SPECIFICITY; AUTOANTIBODIES; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 0038560611     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(01)00007-6     Document Type: Review

References (39)

1. Calabresi P, Thayer WR Jr, Spiro HM. Demonstration of circulating antinuclear globulins in ulcerative colitis. J Clin Invest 1961; 2126-2133.
2. Nielsen H., Wiik A., Elmgreen J. Granulocyte-specific antinuclear antibodies in ulcerative colitis. APMIS. 91:1983;23-26.
3. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS. 97:(suppl. 6):1989;12-13.
4. Snook J.A., Chapman R.W., Fleming K., Jewell D.P. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol. 76:(1):1989;30-33.
5. Seibold F., Weber P., Klein R., Berg P.A., Wiedmann K.H. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut. 33:(5):1992;657-662.
6. Saxon A., Shanahan F., Landers C., Gans T., Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 86:1990;202-210.
7. Rump J.A., Scholmerich J., Gross V., et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiol. 1:1990;406-413.
8. Faber V., Elling P., Norup G., Mansa B., Nissen N.I. An antinuclear factor specific for leucocytes. Lancet. ii:1964;344-345.
9. Wiik A. Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy. 35:1980;263-289.
10. van der Woude F.J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L.A. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. i:1985;425-429.
11. Wiik A., van der Woude F.J. The new ACPA/ANCA nomenclature. Neth J Med. 36:1990;107-108.
12. Terjung B., Spengler U., Sauerbruch T., Worman H.J. 'Atypical p-ANCA' in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology. 119:(2):2000;310-322.
13. Billing P., Tahir S., Calfin B. Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am J Pathol. 147:1995;979-987.
14. Eggena M., Cohavy O., Parseghian M.H., et al. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J Autoimmun. 14:(1):2000;83-97.
15. Sobajima J., Ozaki S., Osakada F., et al. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2. Clin Exp Immunol. 107:1997;135-140.
16. Peen E., Almer S., Bodemar G., et al. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut. 34:1993;56-62.
17. Roozendaal C., Pogany K., Horst G., et al. Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases? Scand J Gastroenterol. 34:(11):1999;1123-1131.
18. Brimnes J., Nielsen O.H., Wiik A., Heegaard N.H.H. Molecular targets of autoantibodies to neutrophils in patients with ulcerative colitis. Dig Dis Sci. 44:1999;415-423.
19. Kossa K., Coulthart A., Ives C.T., Pusey C.D., Hodgson H.J. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 7:(8):1995;783-789.
20. Stoffel M.P., Csernok E., Herzberg C., Johnston T., Caroll S.F., Gross W.L. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol. 104:1996;54-59.
21. Halbwachs-Mecarelli L., Nusbaum P., Noël L.H., et al. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol. 90:1992;79-84.
22. Hagen E.C., Daha M., Hermans J., et al. The diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies (ANCA) in idiopathic systemic vasculitis. Results of an international collaborative study. Kidney Int. 53:1998;743-753.
23. Savige J., Gillis D., Benson E., et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol. 111:(4):1999;507-513.
24. Briggs R.C., Glass W.F., Montiel M.M., Hnilica L.S. Lactoferrin: nuclear localization in the human neutrophilic granulocyte? J Histochem Cytochem. 29:(10):1981;1128-1136.
25. Falk R.J., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 318:1988;1651-1657.
26. Vidrich A., Lee J., James E., Cobb L., Targan S. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis. J Clin Immunol. 15:(6):1995;293-299.
27. Hoffenberg E.J., Fidanza S., Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr. 134:(4):1999;447-452.
28. Ruemmele F.M., Targan S.R., Levy G., Dubinsky M., Braun J., Seidman E.G. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology. 115:(4):1998;822-829.
29. Orth T., Kellner R., Diekmann O., Faust J., Meyer zum Buschenfelde K.H., Mayet W.J. Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol. 112:(3):1998;507-515.
30. Walmsley R.S., Zhao M.H., Hamilton M.I., et al. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gut. 40:(1):1997;105-109.
31. Broekroelofs J., Mulder A.H.L., Nelis G.F., Westerveld B.D., Cohen Tervaert J.W., Kallenberg C.G.M. Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Dig Dis Sci. 39:1994;545-549.
32. Shanahan F., Duerr R.H., Rotter J.I., et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology. 103:(2):1992;456-461.
33. Sobajima J., Ozaki S., Okazaki T., et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type. Clin Exp Immunol. 105:1996;120-124.
34. Targan S.R., Landers C., Vidrich A., Czaja A.J. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology. 108:(4):1995;1159-1166.
35. Wiik A., Munthe E. Complement-fixing granulocyte-specific antinuclear factors in neutropenic cases of rheumatoid arthritis. Immunology. 26:1974;1127-1134.
36. Wiik A. Circulating immune complexes involving granulocyte-specific antinuclear factors in Felty's syndrome and rheumatoid arthritis. Acta Pathol Microbiol Scand sect C. 83:1975;354-364.
37. Wiik A., Jensen E., Friis J. Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis. Ann Rheum Dis. 33:1974;515-522.
38. Coremans I.E.M., Hagen E.C., Daha M.R., et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthr Rheum. 35:1992;1466-1475.
39. Coremans I.E.M., Hagen E.C., van der Voort E.A.M., van der Woude F.J., Daha M.R., Breedveld F.C. Autoantibodies to neutrophil cytoplasmic enzymes in Felty's syndrome. Clin Exp Rheumatol. 11:1993;255-262.